India’s largest pharmaceutical platform by Informa Markets in India will enter its 19th edition with a dual-venue format, delivering on a bigger scale for the pharma value chain.
The CPHI and PMEC India 2026 expansion reflects the growing scale, ambition, and evolution of India’s pharmaceutical ecosystem and the19th edition will be hosted across two world-class venues in Delhi NCR. CPHI India will take place 23–25 November 2026 at IICC, Yashobhoomi, New Delhi, while PMEC India will be organised 24–26 November 2026 at India Expo Mart, Greater Noida. The partially overlapping schedules create a continuous four-day engagement window.
India continues to strengthen its position as one of the world’s most important pharmaceutical hubs and is the third-largest pharmaceutical producer by volume, the country supplies over 20% of global generic medicines while steadily expanding its footprint across APIs, finished dosage formulations, contract manufacturing, biotechnology, and advanced therapies.
The Indian pharmaceutical market is projected to reach approximately US$130bn by 2030, and as regulatory expectations rise globally and supply chains become increasingly interconnected, the need for focused, high-quality industry engagement has become more important than ever.
Speaking on the expansion of the platform, Yogesh Mudras, managing director of the shows’ organiser, Informa Markets in India, said: “The decision to expand CPHI & PMEC India into a two-venue format was driven by research and clear industry feedback. After an 18-month international, consultant-led study and extensive stakeholder consultations, it was evident that the platform had outgrown a single venue. Visitors needed more time, exhibitors needed more space, and both were seeking deeper, more effective engagement. The overlapping schedule effectively adds a fourth day, improving time efficiency, enabling cross-show synergy, and delivering stronger ROI.”
The shows will have a single registration providing real-time access to both venues, dedicated shuttle services, Delhi Metro connectivity, and an enhanced digital platform.
Curated networking, and community-building initiatives, include Women in Pharma, leadership roundtables, more structured exhibition zones, and expanded international participation.
Rahul Deshpande, senior group director, Informa Markets in India, added: “This expansion strengthens the pharmaceutical ecosystem by giving both CPHI India and PMEC India the focus and scale they need to grow, while remaining part of one integrated value-chain platform.”
Discover more about CPHI and PMEC India 2026 here: https://www.cphi.com/india/
Source: www.exhibitionworld.co.uk
Comments are closed.